U.S. FDA nod for Alembic Pharma’s generic of Sandoz’s ophthalmic solution
The Hindu
Alembic Pharma gets U.S. FDA approval for its generic Travoprost ophthalmic solution
More Related News

Insurance penetration and density are often misunderstood and do not reveal how many families are insured or whether they would be financially secure if the main earning member were to die. The real issue is not reach but adequacy, as households may have life insurance but not enough cover to replace lost income, leaving them financially vulnerable.












